Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STAAR SURGICAL CO Director's Dealing 2024

Mar 14, 2024

31996_dirs_2024-03-14_713db9b7-6a35-4259-8d83-7725b3fec523.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STAAR SURGICAL CO (STAA)
CIK: 0000718937
Period of Report: 2024-03-12

Reporting Person: Butcher Arthur C (N/A)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-03-12 Common Stock A 649 $0.00 Acquired 649 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-03-12 Common Stock Options $37.64 A 1163 Acquired 2034-03-11 Common stock (1163) Direct

Footnotes

F1: Effective March 12, 2024, the Board of Directors appointed Mr. Butcher to serve as a member of the Board and granted him, as a non-employee director, 649 restricted shares and options to purchase 1,163 shares of common stock, which represents a pro-rated amount of the standard director equity compensation for a director serving during the 2023-2024 term. These restricted shares and stock options vest in full on the earlier of June 20, 2024, or the Corporation's 2024 Annual Meeting of Shareholders.